Medivation: No to Sanofi’s renewed press to take $9.3B offer
Medivation again rejected Sanofi’s bid to acquire the biologic drugmaker for $9.3 billion, saying Thursday that it “substantially undervalues” Medivation and its prospects. The swift response came hours after Paris-based Sanofi, France’s biggest drugmaker, threatened Medivation’s board members with possible removal if they won’t discuss a deal. Sanofi SA released a letter it sent to […]